Adaptimmune Annual report pursuant to Section 13 and 15(d)

Accrued expenses and other current liabilities

12 Months Ended

Dec. 31, 2016

Note 7 — Accrued expenses and other current liabilities

Accrued expenses and other current liabilities consisted of the following (in thousands):

	December 31, 2016		December 31, 2015		June 30, 2015

Accrued clinical and development expenses	$	4,938	$	3,143	$	1,790
Accrued employee compensation and benefits payable	4,539		2,748		248
Accrued capital expenditure	3,954		42		973
Value added tax	2,014		744		—
Other accrued purchases	1,003		841		826
Other current liabilities	1,080		—		40

	$	17,528	$	7,518	$	3,877